Mizuho Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Mizuho Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$271K	Sell	673 -337	-33%	-$135K	0.06%	231
2016 Q2	$353K	Buy	1,010 +465	+85%	+$179K	0.06%	238
2016 Q1	$246K	Sell	545 -397	-42%	-$164K	0.06%	205
2015 Q4	$511K	Buy	942 +97	+11%	+$52.6K	0.1%	181
2015 Q3	$393K	Buy	845 +185	+28%	+$99.3K	0.09%	190
2015 Q2	$337K	Buy	660 +115	+21%	+$56.1K	0.08%	201
2015 Q1	$246K	Buy	545 +195	+56%	+$82.6K	0.06%	205
2014 Q4	$144K	Buy	350 +105	+43%	+$41.3K	0.04%	223
2014 Q3	$88K	Buy	245 +79	+48%	+$26.5K	0.02%	259
2014 Q2	$47K	Hold	166	–	–	0.01%	330
2014 Q1	$50K	Hold	166	–	–	0.01%	282
2013 Q4	$46K	Hold	166	–	–	0.01%	281
2013 Q3	$52K	Hold	166	–	–	0.01%	273
2013 Q2	$37K	Buy	+166	New	+$38.7K	0.01%	317

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Mizuho Asset Management's REGN Position: Q3 2016 in Review

Mizuho Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 33% in Q3 2016, selling an estimated $135K and leaving 673 shares worth $271K. The position accounts for 0.06% of the portfolio, ranked #231.

Mizuho Asset Management first reported a position in REGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $511K in Q4 2015. 553 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Mizuho Asset Management held 673 shares of Regeneron Pharmaceuticals worth $271K as of Q3 2016.
Mizuho Asset Management sold 337 Regeneron Pharmaceuticals shares in Q3 2016, an estimated $135K.
Regeneron Pharmaceuticals made up 0.06% of Mizuho Asset Management's portfolio in Q3 2016, its #231 holding.
Mizuho Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Mizuho Asset Management's Regeneron Pharmaceuticals position peaked at $511K in Q4 2015.
553 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.